Machine signal
Active cluster sell — 3 distinct insiders, $1.2M, window ends Aug 27, 2026.
Figures computed from official regulatory filings — .
Analysttarget 112.4 USD (-22%)
Ownershipinsiders 5% · institutions 86.26% · short 19.5% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for GRAIL, Inc. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients with clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing, research, and therapy development. In addition, its precision oncology portfolio consists of n RUO-targeted methylation-based platform that enables applications for disease prognostication, risk stratification, minimal residual disease detection, and recurrence and relapse monitoring. The company was incorporated in 2015 and is headquartered in Menlo Park, California.
Market information source · Oct 5, 2026
Periods recorded in the consulted sources. These do not certify the legal dates of name changes.
SEC company identity · Oct 5, 2026
Open-market timeline · full history
4 buys68 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
| Freidin Aaron | Sell | $164.1K | SEC |
| Freidin Aaron | Sell | $49.5K | SEC |
| Ofman Joshua J. | Exercise | $370.3K | SEC |
| Freidin Aaron | Sell | $169K | SEC |
| Ofman Joshua J. | Sell | $136.1K | SEC |
| Ofman Joshua J. | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Ofman Joshua J. | Sell | $137K | SEC |
| Ofman Joshua J. | Sell | $1.1M | SEC |
| Ofman Joshua J. | Sell | $597.9K | SEC |
| Ofman Joshua J. | Sell | $196.2K | SEC |
| Ofman Joshua J. | Sell | $211.4K | SEC |
| Ofman Joshua J. | Sell | $42K | SEC |
| Ofman Joshua J. | Sell | $3.6M | Unusual size | SEC |
| Ofman Joshua J. | Sell | $425.1K | SEC |
| Freidin Aaron | Sell | $671.6K | SEC |
| CHASE WILLIAM J | Award | $20.5K | SEC |
| MIZELL STEVEN | Award | $19.9K | SEC |
| SUMME GREGORY Ltrack record | Award | $31.8K | SEC |
| CHASE WILLIAM J | Award | $350K | Unusual size | SEC |
| SUMME GREGORY Ltrack record | Award | $350K | Unusual size | SEC |
| MIZELL STEVEN | Award | $350K | SEC |
| Krevans Sarah | Award | $350K | SEC |
| Partridge Andrew John | Sell | $91.1K | SEC |
| Ofman Joshua J. | Award | $192.8K | SEC |
| Ofman Joshua J. | Award | $1.8M | SEC |